Tapewire

Nasdaq · USD

ATRC

AtriCure, Inc.

Export transactions ↓
Tapewire entity
2704
SEC CIK
0001323885
Parsed reports
445

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202603
Aug 202603
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 02, 2022 Filed Mar 4, 2022 07:26 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 1,626 $69.31 $112,698.06
Disclosure

SEC source: 0001323885-22-000031 · wf-form4_164639677802377.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,774

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $68.71 to $70.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:32 UTC
Doraiswamy VinayakChief Scientific Officer
Tax withholdingCommon Stock 7,474 $69.59 $520,115.66
Disclosure

SEC source: 0001323885-22-000027 · wf-form4_164634314104929.xml · nonDerivative · entry 3

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,039

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:32 UTC
Doraiswamy VinayakChief Scientific Officer
GrantCommon Stock 6,825 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000027 · wf-form4_164634314104929.xml · nonDerivative · entry 2

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,513

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:32 UTC
Doraiswamy VinayakChief Scientific Officer
GrantCommon Stock 7,789 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000027 · wf-form4_164634314104929.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,688

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:32 UTC
Austin TonyaChief Human Resources Officer
Tax withholdingCommon Stock 5,397 $69.59 $375,577.23
Disclosure

SEC source: 0001323885-22-000026 · wf-form4_164634309410760.xml · nonDerivative · entry 3

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,400

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:32 UTC
Austin TonyaChief Human Resources Officer
GrantCommon Stock 6,466 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000026 · wf-form4_164634309410760.xml · nonDerivative · entry 2

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,797

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:32 UTC
Austin TonyaChief Human Resources Officer
GrantCommon Stock 5,991 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000026 · wf-form4_164634309410760.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,331

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:30 UTC
Dahlquist Karl S.Chief Legal Officer
Tax withholdingCommon Stock 7,299 $69.59 $507,937.41
Disclosure

SEC source: 0001323885-22-000023 · wf-form4_164634299735384.xml · nonDerivative · entry 3

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,140

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:30 UTC
Dahlquist Karl S.Chief Legal Officer
GrantCommon Stock 6,825 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000023 · wf-form4_164634299735384.xml · nonDerivative · entry 2

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,439

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:30 UTC
Dahlquist Karl S.Chief Legal Officer
GrantCommon Stock 7,789 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000023 · wf-form4_164634299735384.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,614

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:31 UTC
Wirick Angela LChief Financial Officer
Tax withholdingCommon Stock 3,449 $69.59 $240,015.91
Disclosure

SEC source: 0001323885-22-000024 · wf-form4_164634303430419.xml · nonDerivative · entry 2

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,037

F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 16:31 UTC
Wirick Angela LChief Financial Officer
GrantCommon Stock 9,340 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000024 · wf-form4_164634303430419.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,486

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:33 UTC
Noznesky Justin JChief Mktg & Strategy Officer
Tax withholdingCommon Stock 7,474 $69.59 $520,115.66
Disclosure

SEC source: 0001323885-22-000029 · wf-form4_164634319843566.xml · nonDerivative · entry 3

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,829

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:33 UTC
Noznesky Justin JChief Mktg & Strategy Officer
GrantCommon Stock 6,825 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000029 · wf-form4_164634319843566.xml · nonDerivative · entry 2

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,303

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:33 UTC
Noznesky Justin JChief Mktg & Strategy Officer
GrantCommon Stock 7,789 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000029 · wf-form4_164634319843566.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,478

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:31 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
Tax withholdingCommon Stock 43,167 $69.59 $3,003,991.53
Disclosure

SEC source: 0001323885-22-000025 · wf-form4_164634306271736.xml · nonDerivative · entry 3

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 534,546

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:31 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GrantCommon Stock 22,632 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000025 · wf-form4_164634306271736.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 577,713

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:31 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GrantCommon Stock 67,109 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000025 · wf-form4_164634306271736.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,081

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:33 UTC
Seith Douglas JChief Operating Officer
Tax withholdingCommon Stock 11,440 $69.59 $796,109.60
Disclosure

SEC source: 0001323885-22-000028 · wf-form4_164634316079039.xml · nonDerivative · entry 3

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,026

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:33 UTC
Seith Douglas JChief Operating Officer
GrantCommon Stock 12,573 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000028 · wf-form4_164634316079039.xml · nonDerivative · entry 2

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,466

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:33 UTC
Seith Douglas JChief Operating Officer
GrantCommon Stock 13,182 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000028 · wf-form4_164634316079039.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,893

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:29 UTC
Privitera SalvatoreChief Technical Officer
Tax withholdingCommon Stock 6,700 $69.59 $466,253.00
Disclosure

SEC source: 0001323885-22-000022 · wf-form4_164634295993514.xml · nonDerivative · entry 3

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,484

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:29 UTC
Privitera SalvatoreChief Technical Officer
GrantCommon Stock 6,825 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000022 · wf-form4_164634295993514.xml · nonDerivative · entry 2

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,184

F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 21:29 UTC
Privitera SalvatoreChief Technical Officer
GrantCommon Stock 7,789 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000022 · wf-form4_164634295993514.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,359

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 13:58 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GiftCommon Stock 510 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000013 · wf-form4_164605671307865.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 487,972

F1 · price: No consideration was received in connection with this gift to the reporting person's children.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 13:58 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GiftCommon Stock 510 $0.00 $0.00
Disclosure

SEC source: 0001323885-22-000013 · wf-form4_164605671307865.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,482

F1 · price: No consideration was received in connection with this gift to the reporting person's children.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 08:01 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 2,490 $67.97 $169,245.30
Disclosure

SEC source: 0001209191-22-009633 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,340

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $67.15 to $68.54 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 14, 2022 Filed Jan 18, 2022 09:05 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 2,719 $66.11 $179,753.09
Disclosure

SEC source: 0001209191-22-003422 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,830

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $65.04 to $66.71 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 13:39 UTC
Doraiswamy VinayakChief Scientific Officer
GrantCommon Stock 24 $59.10 $1,418.40
Disclosure

SEC source: 0001209191-22-000387 · doc4.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,899

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 08:29 UTC
Austin TonyaChief Human Resources Officer
GrantCommon Stock 141 $59.10 $8,333.10
Disclosure

SEC source: 0001209191-22-000378 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,549

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 13:35 UTC
Dahlquist Karl S.Chief Legal Officer
GrantCommon Stock 24 $59.10 $1,418.40
Disclosure

SEC source: 0001209191-22-000384 · doc4.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,825

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 13:31 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GrantCommon Stock 141 $59.10 $8,333.10
Disclosure

SEC source: 0001209191-22-000381 · doc4.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,992

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 13:43 UTC
Privitera SalvatoreChief Technical Officer
GrantCommon Stock 151 $59.10 $8,924.10
Disclosure

SEC source: 0001209191-22-000390 · doc4.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,570

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2021.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2021, which was the last trading day of the applicable offering period. The closing price on December 31, 2021 was $69.53.

Read SEC document
December 10, 2021 Filed Dec 14, 2021 08:32 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 1,528 $70.88 $108,304.64
Disclosure

SEC source: 0001209191-21-069361 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,408

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

Read SEC document
December 07, 2021 Filed Dec 9, 2021 21:19 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-068766 · doc4.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,851

F1 · price: No consideration was received in connection with this charitable gift.

Read SEC document
November 12, 2021 Filed Nov 12, 2021 21:38 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GiftCommon Stock 345 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-064215 · doc4.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 498,851

F1 · price: No consideration was received in connection with this gift to the reporting person's children.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 16:36 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 2,732 $78.55 $214,598.60
Disclosure

SEC source: 0001209191-21-064773 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,936

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $77.76 to $79.28 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2021 Filed Nov 12, 2021 21:38 UTC
CARREL MICHAEL HDirector · President, CEO, & Director
GiftCommon Stock 345 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-064215 · doc4.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 499,196

F1 · price: No consideration was received in connection with this gift to the reporting person's children.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 08:15 UTC
Wirick Angela LChief Financial Officer
SaleCommon Stock 2,604 $85.00 $221,340.00
Disclosure

SEC source: 0001209191-21-063297 · doc4.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,146

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 08:12 UTC SaleCommon Stock 4,000 $80.91 $323,640.00
Disclosure

SEC source: 0001209191-21-063295 · doc4.xml · nonDerivative · entry 1

Collar Mark A · CIK 0001426353 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,307

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $80.00 to $82.11 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 08, 2021 Filed Oct 12, 2021 08:14 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 665 $71.80 $47,747.00
Disclosure

SEC source: 0001209191-21-060153 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,668

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 20:45 UTC SaleCommon Stock 3,156 $74.73 $235,847.88
Disclosure

SEC source: 0001209191-21-056653 · doc4.xml · nonDerivative · entry 1

GROVES REGINA E · CIK 0001653877 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,194

F1 · price: This transaction was executed in multiple trades at prices ranging from $73.17 to $75.37 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 20:38 UTC
Seith Douglas JChief Operating Officer
SaleCommon Stock 21,444 $75.54 $1,619,879.76
Disclosure

SEC source: 0001209191-21-056180 · doc4.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,711

F1 · price: This transaction was executed in multiple trades at prices ranging from $74.91 to $76.06 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 10, 2021 Filed Sep 14, 2021 08:16 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 1,227 $77.18 $94,699.86
Disclosure

SEC source: 0001209191-21-055813 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,333

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

Read SEC document
August 13, 2021 Filed Aug 17, 2021 08:29 UTC
Austin TonyaChief Human Resources Officer
SaleCommon Stock 3,232 $73.10 $236,259.20
Disclosure

SEC source: 0001209191-21-051752 · doc4.xml · nonDerivative · entry 1

Austin Tonya · CIK 0001861968 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,560

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $72.66 to $73.68 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 09, 2021 Filed Aug 11, 2021 21:17 UTC
Seith Douglas JChief Operating Officer
SaleCommon Stock 7,065 $80.79 $570,781.35
Disclosure

SEC source: 0001209191-21-050943 · doc4.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,155

F1 · price: This transaction was executed in multiple trades at prices ranging from $80.00 to $82.57 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 06, 2021 Filed Aug 10, 2021 08:06 UTC
Wirick Angela LChief Financial Officer
Tax withholdingCommon Stock 5,191 $83.75 $434,746.25
Disclosure

SEC source: 0001209191-21-050515 · doc4.xml · nonDerivative · entry 2

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,750

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.

Read SEC document
August 06, 2021 Filed Aug 10, 2021 08:06 UTC
Wirick Angela LChief Financial Officer
SaleCommon Stock 5,939 $80.21 $476,367.19
Disclosure

SEC source: 0001209191-21-050515 · doc4.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,941

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $78.52 to $81.50 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 30, 2021 Filed Aug 3, 2021 12:11 UTC
Privitera SalvatoreChief Technical Officer
SaleCommon Stock 8,808 $85.00 $748,680.00
Disclosure

SEC source: 0001209191-21-049167 · doc4.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,419

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

Read SEC document
July 28, 2021 Filed Jul 30, 2021 12:41 UTC
Privitera SalvatoreChief Technical Officer
SaleCommon Stock 8,000 $82.50 $660,000.00
Disclosure

SEC source: 0001209191-21-048737 · doc4.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,227

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.